Inflammation and ER Stress Downregulate BDH2 Expression and Dysregulate Intracellular Iron in Macrophages
Table 1
Cytokine and chemokine release from THP-1 cells.
Cytokine/chemokine release (pg/mL)
No treatment
Tunicamycin (10 µg/mL)a,b
LPS (40 ng/mL)a,b,c,#
Tunicamycin + LPSa,c
IL-1β
11.4 ± 0.1
411.6 ± 25.7
515 ± 54
415.3 ± 62
value < 0.0001a
NSb
NSc
IL-13
13.1 ± 1.3
18 ± 2.5
19.43 ± 2.5
21.24 ± 2.2
value = 0.0142a
NSb
NSc
IL-6
5.69 ± 0.1
23.6 ± 13.7
47.2 ± 20
225 ± 31
value < 0.0001a
NSb
<0.0001c
IL-12p40
2.9 ± 2.1
190 ± 232
1913 ± 228
323 ± 234
value < 0.0001a
<0.0001b
<0.0001c
GM-CSF
ND!
2.02 ± 0.7
2.98 ± 0.39
3.7 ± 0.38
value < 0.0001a
NSb
NSc
IFNα
7.81 ± 1.4
21.8 ± 6.2
35.9 ± 0.73
28.8 ± 4.6
value = 0.0001a
<0.01b
NSc
IL-1R antagonist
11.33 ± 6.6
430.9 ± 114
1071 ± 164
528 ± 41.2
value < 0.0001a
<0.0001b
<0.001c
TNFα
0.714 ± 0.15
40.2 ± 58
245.2 ± 152
30.8 ± 38
value = 0.025a
NSb
NSc
IL-2R
2.27 ± 3.0
47.9 ± 35.8
122.8 ± 7.7
102.7 ± 10.4
value = 0.0002a
<0.001b
NSc
RANTES
67 ± 48.7
373 ± 169
756 ± 82
480 ± 112
value = 0.0005a
<0.01b
NSc
MIP1α
34.29 ± 0
1010 ± 1493
5404 ± 394
2279 ± 397
value = 0.001a
<0.001b
<0.01c
MIP1β
9.8 ± 0
1913 ± 1750
8295 ± 1895
3902 ± 551
value = 0.0003a
<0.001b
<0.01c
MCP-1
5.09 ± 2.2
274 ± 94
336 ± 68
417 ± 118
value = 0.0015a
NSb
NSc
IP-10 (CXCL10)
4.0 ± 3.5
67.5 ± 56
104.4 ± 67
55.1 ± 29
value = 0.139a
NSb
NSc
IL-8
15.4 ± 5.7
6832 ± 542
7034 ± 848
6832 ± 598
value < 0.0001a
NSb
NSc
ND: not detected.
a values calculated in reference to no treatment using one-way ANOVA.
b values of LPS treatment (#) compared to tunicamycin using Bonferroni’s multiple comparison test.
c values of LPS treatment (#) compared to tunicamycin + LPS using Bonferroni’s multiple comparison test. NS: not significant.